drugs for urinary incontinence/retention Flashcards
antimuscarinic quaternary amine
trospium
antimuscarinic metabolism and elimination
CYP matabolism (3A4 and 2D6) and urinary elimination; exception: trospium - no cyp metab; rapid hydrolysis
antimuscarinic with >M3 selectivity
darifenacin
antimuscarinic issues
urinary retention;
CV effects-palpitations, tachycardia, QT prolongation;
GI effects: constipation
CNS: sedation, confusion, hallucinations, sleep disruption
anticholinergics
darifenacin, fesoterodine, oxybutynin, solifenacin, tolterodine, trospium, botulinum toxin
sympathomimetics
mirabegron, pseudoephedrine, ephedra
botox moa
inhibition of vesicular release of excitatory neurotransmitters and axonal expression of other SNARE-complex-dependent proteins in the urothelium/suburothelium mediating intrinsic or spinal reflexes thought to cause detrusor overactivity
mirabegron metabolism
CYP3A4»2D6, butylcholinesterase, UGT, and alcohol dehydrogenase
mirabegron adverse effects
HTN (need to monitor) and tachycardia
pseudoephedrine adverse effects
HTN, tachycardia, atrial fibrillation, anxiety and restlessness, MAOI interaction
ephedra adverse effects
HTN, tachyarrhythmia, CHF, MI, insomnia, symptoms of CNS stimulation, MAOI interaction
methionine moa
creates ammonia-free urine by acidifying urine pH
bovine collagen use
incontinance due to sphincter deficiency
bovine collagen adverse effects
forms a soft cohesive network of fibers increasing tissue bulk around the urethral lumen
bovine collagen adverse effects
urinary retention, hematuria, injection site reaction, worsening incontinence, erythema, urticaria, abscess formation